Parameter | Pre-infliximab (baseline) | Post-infliximab (4 doses; week 14) | Outcome |
---|---|---|---|
Mean tender joints (n) | 17.1 | 7.3 | 57% reduction |
Mean swollen joints (n) | 11.2 | 3.8 | 66% reduction |
ESR (mm/h) | 33 | 26.5 | 20% reduction |
Mean prednisone dosage (mg/day) | 9.2 | 5.7 | 38% reduction |